REQUEST A DEMO
Total
USD $0.00
Search more companies

Jorge Ariel Restrepo Orrego (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Jorge Ariel Restrepo Orrego Profile Updated: June 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Jorge Ariel Restrepo Orrego is an enterprise located in Colombia, with the main office in Bogota D.C.. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on April 23, 1991. It currently has a total number of 1 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 7.64% in 2023. Its’ total assets recorded a growth of 3.3%. The enterprise’s net profit margin increased by 2.39% in 2023.

Headquarters
Cl 114 No 6 A - 92 Lc D 333
Bogota D.C.; Bogota D.C; Postal Code: 1002

Contact Details: Purchase the Jorge Ariel Restrepo Orrego report to view the information.

Basic Information
Total Employees:
Purchase the Jorge Ariel Restrepo Orrego report to view the information.
Outstanding Shares:
Purchase the Jorge Ariel Restrepo Orrego report to view the information.
Incorporation Date:
April 23, 1991
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Jorge Ariel Restrepo Orrego report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
7.64%
Total operating revenue
7.64%
Operating profit (EBIT)
37.88%
Net Profit (Loss) for the Period
37.88%
Total assets
3.3%
Total equity
3.3%
Operating Profit Margin (ROS)
2.39%
Net Profit Margin
2.39%
Return on Equity (ROE)
1.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?